Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke : Secondary Analysis of Cardiovascular Outcome Trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.1161/STROKEAHA.122.042053
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2023
- Creator
-
Balasubramanian, Priyadarshini
Kernan, Walter N.
Sheth, Kevin N.
Ofstad, Anne Pernille
Rosenstock, Julio
Wanner, Christoph
Zinman, Bernard
Mattheus, Michaela
Marx, Nikolaus
Inzucchi, Silvio E.
- DOI
-
10.18154/RWTH-CONV-252137
- URN
-
urn:nbn:de:101:1-2405080135417.306156694881
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Balasubramanian, Priyadarshini
- Kernan, Walter N.
- Sheth, Kevin N.
- Ofstad, Anne Pernille
- Rosenstock, Julio
- Wanner, Christoph
- Zinman, Bernard
- Mattheus, Michaela
- Marx, Nikolaus
- Inzucchi, Silvio E.
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2023
Other Objects (12)
Peroxisome proliferator-activated receptors als Modulatoren der inflammatorischen Reaktion in der Atherogenese
COVID-19 and Cardiovascular Comorbidities
High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms
SGLT2 inhibitors in heart failure and type 2 diabetes : from efficacy in trials towards effectiveness in the real world
Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits
Cardiovascular Disease in Chronic Kidney Disease : Pathophysiological Insights and Therapeutic Options
Diabetes
Diabetes Mellitus and Heart Failure
Diabetes Mellitus and Heart Failure
Dapagliflozin, advanced chronic kidney disease, and mortality : new insights from the DAPA-CKD trial
Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events
Platelet Reactivity and Cardiovascular Mortality Risk in the LURIC Study
Peroxisome proliferator-activated receptors als Modulatoren der inflammatorischen Reaktion in der Atherogenese
COVID-19 and Cardiovascular Comorbidities
High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms
SGLT2 inhibitors in heart failure and type 2 diabetes : from efficacy in trials towards effectiveness in the real world
Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits
Cardiovascular Disease in Chronic Kidney Disease : Pathophysiological Insights and Therapeutic Options
Diabetes
Diabetes Mellitus and Heart Failure
Diabetes Mellitus and Heart Failure
Dapagliflozin, advanced chronic kidney disease, and mortality : new insights from the DAPA-CKD trial
Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events
Platelet Reactivity and Cardiovascular Mortality Risk in the LURIC Study
Peroxisome proliferator-activated receptors als Modulatoren der inflammatorischen Reaktion in der Atherogenese
COVID-19 and Cardiovascular Comorbidities
High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms
SGLT2 inhibitors in heart failure and type 2 diabetes : from efficacy in trials towards effectiveness in the real world
Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits
Cardiovascular Disease in Chronic Kidney Disease : Pathophysiological Insights and Therapeutic Options
Diabetes
Diabetes Mellitus and Heart Failure
Diabetes Mellitus and Heart Failure
Dapagliflozin, advanced chronic kidney disease, and mortality : new insights from the DAPA-CKD trial
Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events